Top Clinical Trials companies in India by Capital Expenditure
India
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD -426.99 M
|
March 31, 2024 | USD 13.22 | -1.73% |
|
India |
|
| 2 |
USD -328.92 M
|
March 31, 2024 | USD 13.94 | -0.13% |
|
India |
|
| 3 |
USD -231.58 M
|
March 31, 2024 | USD 4.17 | -3.26% |
|
India |
|
| 4 |
USD -161.77 M
|
March 31, 2024 | USD 16.74 | 0.39% |
|
India |
|
| 5 |
USD -111.37 M
|
March 31, 2024 | USD 23.82 | -3.94% |
|
India |
|
| 6 |
USD -108.69 M
|
March 31, 2024 | USD 10.85 | -1.55% |
|
India |
|
| 7 |
USD -107.71 M
|
March 31, 2024 | USD 16.74 | -3.08% |
|
India |
|
| 8 |
USD -107.63 M
|
March 31, 2024 | USD 11.46 | 0.36% |
|
India |
|
| 9 |
USD -81.32 M
|
March 31, 2024 | USD 7.01 | -2.13% |
|
India |
|
| 10 |
USD -58.99 M
|
March 31, 2024 | USD 8.32 | -1.15% |
|
India |
|
| 11 |
USD -51.89 M
|
March 31, 2024 | USD 35.78 | -1.94% |
|
India |
|
| 12 |
USD -49.31 M
|
March 31, 2024 | USD 16.36 | -1.17% |
|
India |
|
| 13 |
USD -46.75 M
|
March 31, 2024 | USD 16.72 | -0.99% |
|
India |
|
| 14 |
USD -45.84 M
|
March 31, 2024 | USD 28.23 | -1.30% |
|
India |
|
| 15 |
USD -45.63 M
|
March 31, 2024 | USD 6.36 | -2.20% |
|
India |
|
| 16 |
USD -40.69 M
|
March 31, 2024 | USD 14.31 | -2.32% |
|
India |
|
| 17 |
USD -39.26 M
|
March 31, 2024 | USD 10.00 | -1.50% |
|
India |
|
| 18 |
USD -34.45 M
|
March 31, 2024 | USD 9.81 | -4.71% |
|
India |
|
| 19 |
USD -32.87 M
|
March 31, 2024 | USD 4.24 | -2.07% |
|
India |
|
| 20 |
USD -31.34 M
|
March 31, 2024 | USD 18.58 | -3.14% |
|
India |
|
| 21 |
USD -27.14 M
|
March 31, 2024 | USD 4.54 | -1.98% |
|
India |
|
| 22 |
USD -25.90 M
|
March 31, 2024 | USD 16.63 | -4.25% |
|
India |
|
| 23 |
USD -25.04 M
|
March 31, 2024 | USD 2.90 | -5.10% |
|
India |
|
| 24 |
USD -17.46 M
|
March 31, 2024 | USD 7.86 | -5.01% |
|
India |
|
| 25 |
USD -17.22 M
|
March 31, 2024 | USD 157.44 | -6.12% |
|
India |
|
| 26 |
USD -15.49 M
|
March 31, 2024 | USD 15.36 | -4.42% |
|
India |
|
| 27 |
USD -14.17 M
|
March 31, 2024 | USD 7.96 | -5.16% |
|
India |
|
| 28 |
USD -13.51 M
|
March 31, 2024 | USD 4.54 | -3.97% |
|
India |
|
| 29 |
USD -11.20 M
|
March 31, 2024 | USD 5.32 | 1.01% |
|
India |
|
| 30 |
USD -10.27 M
|
March 31, 2024 | USD 24.55 | -3.90% |
|
India |
|
| 31 |
USD -9.32 M
|
March 31, 2024 | USD 4.07 | -9.29% |
|
India |
|
| 32 |
USD -9.18 M
|
March 31, 2024 | USD 12.04 | -1.03% |
|
India |
|
| 33 |
USD -8.86 M
|
March 31, 2024 | USD 1.14 | -4.23% |
|
India |
|
| 34 |
USD -7.77 M
|
March 31, 2024 | USD 14.32 | -3.90% |
|
India |
|
| 35 |
USD -7.64 M
|
March 31, 2024 | USD 20.54 | -0.02% |
|
India |
|
| 36 |
USD -7.38 M
|
March 31, 2024 | USD 8.63 | -2.94% |
|
India |
|
| 37 |
USD -7.14 M
|
March 31, 2024 | USD 2.87 | -3.41% |
|
India |
|
| 38 |
USD -6.79 M
|
March 31, 2024 | USD 1.96 | -3.91% |
|
India |
|
| 39 |
USD -6.25 M
|
March 31, 2024 | USD 2.30 | -4.45% |
|
India |
|
| 40 |
USD -6.21 M
|
March 31, 2024 | USD 12.49 | -2.13% |
|
India |
|
| 41 |
USD -5.79 M
|
March 31, 2024 | USD 335.54 | -1.09% |
|
India |
|
| 42 |
USD -5.50 M
|
March 31, 2024 | USD 1.13 | -4.28% |
|
India |
|
| 43 |
USD -5.34 M
|
March 31, 2024 | USD 1.10 | -1.87% |
|
India |
|
| 44 |
USD -4.92 M
|
March 31, 2024 | USD 6.00 | -1.32% |
|
India |
|
| 45 |
USD -4.12 M
|
Dec. 31, 2023 | USD 61.89 | -0.04% |
|
India |
|
| 46 |
USD -3.74 M
|
March 31, 2024 | USD 23.71 | -3.13% |
|
India |
|
| 47 |
USD -3.69 M
|
March 31, 2024 | USD 1.75 | -2.24% |
|
India |
|
| 48 |
USD -3.63 M
|
March 31, 2024 | USD 6.81 | -4.55% |
|
India |
|
| 49 |
USD -3.53 M
|
March 31, 2024 | USD 0.37 | -8.26% |
|
India |
|
| 50 |
USD -3.42 M
|
March 31, 2024 | USD 14.60 | -15.38% |
|
India |
Frequently Asked Questions
-
Which Clinical Trials company in India has the highest Capital Expenditure ?
The Clinical Trials company in India with the highest Capital Expenditure is Aurobindo Pharma Limited (NSE: AUROPHARMA.NS) at USD -426.99 M.
-
Which Clinical Trials company in India has the lowest Capital Expenditure ?
The Clinical Trials company in India with the lowest Capital Expenditure is Suven Life Sciences Limited (NSE: SUVEN.NS) at USD 0.00.
-
What are the top 10 Clinical Trials companies in India by Capital Expenditure ?
The top 10 Clinical Trials companies in India by Capital Expenditure are Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Biocon Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, Jubilant Pharmova Limited, Laurus Labs Limited and Syngene International Limited.
-
What are the bottom 10 Clinical Trials companies in India by Capital Expenditure ?
The bottom 10 Clinical Trials companies in India by Capital Expenditure are Suven Life Sciences Limited, Vaishali Pharma Limited, Vineet Laboratories Limited, Jagsonpal Pharmaceuticals Limited, Medico Remedies Limited, Kilitch Drugs (India) Limited, TAKE Solutions Limited, Syncom Formulations (India) Limited, Lyka Labs Limited and Krebs Biochemicals & Industries Limited.
